Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arnold Bolomsky

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Seminars in Oncology|February 7, 2022
Pathogenic signaling in multiple myelomaArnold Bolomsky, Ryan M Young
Methods in Molecular Biology (Clifton, N.J.)|October 18, 2024
Genotype from Phenotype: Using CRISPR Screens to Dissect Lymphoma BiologyArnold Bolomsky, Jaewoo Choi, James D Phelan
Cancers|December 10, 2021
Stratification for RRMM and Risk-Adapted Therapy: Sequencing of Therapies in RRMMGeorg Jeryczynski, Arnold Bolomsky, Hermine Agis, et al.
Journal of Hematology & Oncology|March 4, 2016
Targeting of BMI-1 with PTC-209 shows potent anti-myeloma activity and impairs the tumour microenvironmentArnold Bolomsky, Karin Schlangen, Wolfgang Schreiner, et al.
Methods in Molecular Biology (Clifton, N.J.)|October 18, 2024
Use of Proximity Ligation Assay to Study Lymphoid MalignanciesKristina Rinaldi, Arnold Bolomsky, Jan Wisniewski, et al.
Leukemia & Lymphoma|March 22, 2016
Monokine induced by interferon gamma (MIG/CXCL9) is an independent prognostic factor in newly diagnosed myelomaArnold Bolomsky, Martin Schreder, Wolfgang Hübl, et al.
Experimental Hematology|April 8, 2014
Immunomodulatory drugs thalidomide and lenalidomide affect osteoblast differentiation of human bone marrow stromal cells in vitroArnold Bolomsky, Martin Schreder, Tobias Meißner, et al.
Journal of Hematology & Oncology|December 14, 2020
MCL-1 inhibitors, fast-lane development of a new class of anti-cancer agentsArnold Bolomsky, Meike Vogler, Murat Cem Köse, et al.
Journal of Cancer Research and Clinical Oncology|June 23, 2012
Induction of indoleamine-2,3 dioxygenase in bone marrow stromal cells inhibits myeloma cell growthSabine Pfeifer, Martin Schreder, Arnold Bolomsky, et al.
Haematologica|November 11, 2017
Maternal embryonic leucine zipper kinase is a novel target for proliferation-associated high-risk myelomaArnold Bolomsky, Roy Heusschen, Karin Schlangen, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Seminars in Oncology|February 7, 2022
Pathogenic signaling in multiple myelomaArnold Bolomsky, Ryan M Young
Methods in Molecular Biology (Clifton, N.J.)|October 18, 2024
Genotype from Phenotype: Using CRISPR Screens to Dissect Lymphoma BiologyArnold Bolomsky, Jaewoo Choi, James D Phelan
Cancers|December 10, 2021
Stratification for RRMM and Risk-Adapted Therapy: Sequencing of Therapies in RRMMGeorg Jeryczynski, Arnold Bolomsky, Hermine Agis, et al.
Journal of Hematology & Oncology|March 4, 2016
Targeting of BMI-1 with PTC-209 shows potent anti-myeloma activity and impairs the tumour microenvironmentArnold Bolomsky, Karin Schlangen, Wolfgang Schreiner, et al.
Methods in Molecular Biology (Clifton, N.J.)|October 18, 2024
Use of Proximity Ligation Assay to Study Lymphoid MalignanciesKristina Rinaldi, Arnold Bolomsky, Jan Wisniewski, et al.
Leukemia & Lymphoma|March 22, 2016
Monokine induced by interferon gamma (MIG/CXCL9) is an independent prognostic factor in newly diagnosed myelomaArnold Bolomsky, Martin Schreder, Wolfgang Hübl, et al.
Experimental Hematology|April 8, 2014
Immunomodulatory drugs thalidomide and lenalidomide affect osteoblast differentiation of human bone marrow stromal cells in vitroArnold Bolomsky, Martin Schreder, Tobias Meißner, et al.
Journal of Hematology & Oncology|December 14, 2020
MCL-1 inhibitors, fast-lane development of a new class of anti-cancer agentsArnold Bolomsky, Meike Vogler, Murat Cem Köse, et al.
Journal of Cancer Research and Clinical Oncology|June 23, 2012
Induction of indoleamine-2,3 dioxygenase in bone marrow stromal cells inhibits myeloma cell growthSabine Pfeifer, Martin Schreder, Arnold Bolomsky, et al.
Haematologica|November 11, 2017
Maternal embryonic leucine zipper kinase is a novel target for proliferation-associated high-risk myelomaArnold Bolomsky, Roy Heusschen, Karin Schlangen, et al.
Pageof 3